Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease
- PMID: 31560761
- DOI: 10.1093/ibd/izz228
Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease
Comment in
-
Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".Inflamm Bowel Dis. 2019 Nov 14;25(12):e159. doi: 10.1093/ibd/izz230. Inflamm Bowel Dis. 2019. PMID: 31560772 No abstract available.
Comment on
-
Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.Inflamm Bowel Dis. 2019 Jun 18;25(7):1120-1128. doi: 10.1093/ibd/izy402. Inflamm Bowel Dis. 2019. PMID: 30772902
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
